Geoff Meyerson
Vorstandsvorsitzender bei Locust Walk Securities LLC
Profil
Mr. Geoffrey H.
Meyerson is a Chief Executive Officer & Co-Founder at Locust Walk Securities LLC and a Chief Executive Officer at Locust Walk Partners LLC.
He is on the Board of Directors at AI Proteins, Inc.
Prior to Locust Walk, Mr. Meyerson worked in business development at a venture-backed biotech company, Zelos Therapeutics, where he was on the management team and negotiated a drug delivery collaboration with Aegis Therapeutics.
Before Zelos, he worked as a venture capitalist at SR One, the venture capital subsidiary of GlaxoSmithKline, where he closed eight financings in the US and Europe.
He also worked at MedImmune in business development helping with their small molecule strategy.
He holds an MBA in Health Care Management from the Wharton School, a Masters in Biotechnology from the University of Pennsylvania, and a BS in Economics from Duke University.
Aktive Positionen von Geoff Meyerson
| Unternehmen | Position | Beginn |
|---|---|---|
Locust Walk Securities LLC
 Locust Walk Securities LLC Investment Banks/BrokersFinance Locust Walk Securities LLC is a securities brokerage firm headquartered in Boston, Massachusetts. The firm was founded by Geoffrey Meyerson and Joseph Mohr in 2011 and they are a subsidiary of Locust Walk Partners LLC. Locust Walk Securities serves as the broker-dealer for all Locust Walk engagements – enabling them to execute a wider range of securities-related transactions for their clients, which includes mergers and acquisitions, private placements and mezzanine financings, and partnerships involving equity investments. | Vorstandsvorsitzender | 01.01.2011 |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Vorstandsvorsitzender | 01.12.2008 |
Ehemalige bekannte Positionen von Geoff Meyerson
| Unternehmen | Position | Ende |
|---|---|---|
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Locust Walk Securities LLC
Locust Walk Securities LLC Investment Banks/BrokersFinance Locust Walk Securities LLC is a securities brokerage firm headquartered in Boston, Massachusetts. The firm was founded by Geoffrey Meyerson and Joseph Mohr in 2011 and they are a subsidiary of Locust Walk Partners LLC. Locust Walk Securities serves as the broker-dealer for all Locust Walk engagements – enabling them to execute a wider range of securities-related transactions for their clients, which includes mergers and acquisitions, private placements and mezzanine financings, and partnerships involving equity investments. | Finance |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Commercial Services |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Health Technology |
